Full Text View
Tabular View
Study Results
Related Studies
Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis
This study has been completed.
Study NCT00548249   Information provided by Rockwell Medical Technologies, Inc.

First Received on October 19, 2007.   Last Updated on February 7, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Kidney Disease
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
Standard Bicarbonate Solution
Soluble Ferric Pyrophosphate
Additional drug interventions recognized in this trial
Iron
More general drug interventions related to this trial
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Trace Elements
Sponsors listed in this trial
Rockwell Medical Technologies, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services